Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KYLE VAN SCHWICKERATH

Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery

NPI
1245857101
CMS profile
8723513
Location
SCOTTSDALE, AZ

General Payments · PY2020–2024

$10,335.19

  • Reported across 108 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,227.59

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $1,518.76 8
Food and Beverage $708.83 29

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
VILEX LLC $1,742.76 12
Amgen Inc. $191.85 10
DEXCOM, INC. $40.97 2
BioWound Solutions, Inc. $39.66 2
Novo Nordisk AS $38.08 2
MannKind Corporation $31.39 1
Lilly USA, LLC $28.32 2
ABBVIE INC. $27.33 1
Xeris Pharmaceuticals, Inc. $21.98 1
Verity Pharmaceuticals Inc. $20.98 1
IBSA Pharma Inc. $15.16 1
Paratek Pharmaceuticals, Inc. $15.04 1
IDORSIA PHARMACEUTICALS US INC $14.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $491.15 3
PY2021 $3,340.00 21
PY2022 $3,200.66 33
PY2023 $1,075.79 14
PY2024 $2,227.59 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $27.33 07/24/2024 Food and Beverage Undisputed 01/23/2026 1106046746 CMS
Amgen Inc. $19.24 01/23/2024 Food and Beverage Undisputed 01/23/2026 1117377712 CMS
Amgen Inc. $23.11 02/20/2024 Food and Beverage Undisputed 01/23/2026 1117377714 CMS
Amgen Inc. $19.54 03/08/2024 Food and Beverage Undisputed 01/23/2026 1111701132 CMS
Amgen Inc. $21.73 03/13/2024 Food and Beverage Undisputed 01/23/2026 1117377716 CMS
Amgen Inc. $5.46 03/27/2024 Food and Beverage Undisputed 01/23/2026 1111701134 CMS
Amgen Inc. $24.32 04/11/2024 Food and Beverage Undisputed 01/23/2026 1117377718 CMS
Amgen Inc. $27.74 05/09/2024 Food and Beverage Undisputed 01/23/2026 1117377720 CMS
Amgen Inc. $15.54 05/20/2024 Food and Beverage Undisputed 01/23/2026 1111701136 CMS
Amgen Inc. $6.06 06/13/2024 Food and Beverage Undisputed 01/23/2026 1111701138 CMS
Amgen Inc. $29.11 07/15/2024 Food and Beverage Undisputed 01/23/2026 1117377722 CMS
BioWound Solutions, Inc. $7.01 09/11/2024 Food and Beverage Undisputed 01/23/2026 1118399562 CMS
BioWound Solutions, Inc. $32.65 09/26/2024 Food and Beverage Undisputed 01/23/2026 1118399578 CMS
Dexcom, Inc. $27.18 04/29/2024 Food and Beverage Undisputed 01/23/2026 1153315222 CMS
Dexcom, Inc. $13.79 06/10/2024 Food and Beverage Undisputed 01/23/2026 1153315224 CMS
IBSA Pharma Inc. $15.16 10/07/2024 Food and Beverage Undisputed 01/23/2026 1142975273 CMS
IDORSIA PHARMACEUTICALS US INC $14.07 03/21/2024 Food and Beverage Undisputed 01/23/2026 1146774418 CMS
Lilly USA, LLC $13.82 06/17/2024 Food and Beverage Undisputed 01/23/2026 1135142293 CMS
Lilly USA, LLC $14.50 08/22/2024 Food and Beverage Undisputed 01/23/2026 1135143265 CMS
Mannkind Corporation $31.39 01/11/2024 Food and Beverage Undisputed 01/23/2026 1145849331 CMS
Novo Nordisk Inc $19.94 02/14/2024 Food and Beverage Undisputed 01/23/2026 1097040851 CMS
Novo Nordisk Inc $18.14 03/08/2024 Food and Beverage Undisputed 01/23/2026 1097074861 CMS
Paratek Pharmaceuticals, Inc. $15.04 01/21/2024 Food and Beverage Undisputed 01/23/2026 1113918058 CMS
Verity Pharmaceuticals Inc. $20.98 09/03/2024 Food and Beverage Undisputed 01/23/2026 1080604796 CMS
VILEX LLC $529.26 05/08/2024 Travel and Lodging Undisputed 01/23/2026 1154915061 CMS
VILEX LLC $266.90 05/08/2024 Travel and Lodging Undisputed 01/23/2026 1154915069 CMS
VILEX LLC $361.20 05/08/2024 Travel and Lodging Undisputed 01/23/2026 1154915803 CMS
VILEX LLC $22.50 05/09/2024 Travel and Lodging Undisputed 01/23/2026 1154915065 CMS
VILEX LLC $22.50 05/09/2024 Travel and Lodging Undisputed 01/23/2026 1154915127 CMS
VILEX LLC $51.00 05/09/2024 Food and Beverage Undisputed 01/23/2026 1154915213 CMS
VILEX LLC $61.00 05/09/2024 Food and Beverage Undisputed 01/23/2026 1154915257 CMS
VILEX LLC $22.50 05/10/2024 Travel and Lodging Undisputed 01/23/2026 1154915147 CMS
VILEX LLC $27.00 05/10/2024 Travel and Lodging Undisputed 01/23/2026 1154915171 CMS
VILEX LLC $51.00 05/10/2024 Food and Beverage Undisputed 01/23/2026 1154915245 CMS
VILEX LLC $61.00 05/10/2024 Food and Beverage Undisputed 01/23/2026 1154915251 CMS
VILEX LLC $266.90 05/11/2024 Travel and Lodging Undisputed 01/23/2026 1154915193 CMS
Xeris Pharmaceuticals, Inc. $21.98 08/30/2024 Food and Beverage Undisputed 01/23/2026 1144602111 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.